Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 132,000 shares at $24.19 ($3.2M) on 2021-09-27, disclosed to the SEC on 2021-09-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.40 | 36,000 | $842K | 26.6% |
| 2 | $24.19 | 45,768 | $1.1M | 35.0% |
| 3 | $24.19 | 45,768 | $1.1M | 35.0% |
| 4 | $24.86 | 2,232 | $55K | 1.8% |
| 5 | $24.86 | 2,232 | $55K | 1.8% |
| Total | $24.00 avg | 132,000 |
| $3.2M |
| 100% |
| Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |
| MYOV | BUY | 2021-08-24 | $4.4M | — | Filing → |